Acsis, Inc.  Resource Library

Leveraging our deep shop floor expertise and history, ProducTrak modules are industry-leading offerings that help manufacturers and distributors ensure end-to-end traceability and event management.

 

 
  • How to Counter the Counterfeiters - Serialization

    White Papers

    First published in 20/20 Pharma Magazine, this feature highlights the many ways in which counterfeit drugs are making their way into the public's hands and what organizations can do to put a stop to it. John DiPalo, CTO at Acsis, Inc., joins Reid Graves from Merck and his panel of industry leaders to tackle the problem with serialization.

  • An Empirical Analysis of the Effect of Supply Chain Disruptions on Operating Performance

    White Papers

    This paper documents the impact of supply chain disruptions on operating performance. Based on a sample of 885 disruptions announced by publicly traded firms, we estimate that in the year leading to the announcement, firms on average experience a 107% drop in their operating income, 114% drop in return on sales and 93% drop in return on assets. During this time period the level of return on sales drops by 13.78% and return on assets by 2.32%. Firms that experience disruptions face on average 6.92% lower sales growth, 10.66% growth in cost, and 13.88% growth in inventories.

  • Reducing Risk in Global Supply Chains

    White Papers

    Estimates on counterfeit trade exceed two hundred billion dollars (US). And inspections across the world cost billions, yet only a very few shipments are actually inspected. This issue has particularly impacted the vital Life Sciences Supply Chain. This article discusses some solutions that are at hand to reduce illicit trade and ensure a safe and secure supply of pharmaceuticals.

  • Mass Serialization Strategies for the Pharmaceutical Industry

    White Papers

    Six million counterfeit cosmetics/personal care products and 1.2 million foodstuffs and beverage products were seized at the European Union (EU) border last year. In addition, counterfeit medicines had 2.7 million products stopped at the border. Stateside, U.S. Customs and Border Protection’s (CBP) Office of International Trade announced that the domestic value of counterfeit and pirated products seized by CBP and U.S. Immigration and Customs Enforcement (ICE) increased by 2.7% in mid-fiscal year 2008 over 2007.